Each CEOS agency will continue to develop its data and computational infrastructures consistent with FDA-10: Finalise inventory its capacity and user service mandates. CEOS has a of Software and Tools role in identifying tools to support available or used at CEOS complementarity and interoperability across CEOS agencies for EO data agencies in support of the FDA strategy objectives. exploitation and use focusing on Open Source Q3 2018 WGISS WGISS will finalise the ongoing work of but remaining as broad inventorying the software and tools available or and inclusive as possible used at CEOS agencies for EO data exploitation and and implement a use (e.g. EO data visualization, analysis, mechanism for discovery processing, readers/writers, etc), and implement a and access. mechanism for discovery and access. Focus will be on Open Source but remaining as broad and inclusive as possible. Data, Processing, and Architecture Interface Standards Several CEOS agencies have already carried out initial pilot projects and CEOS seeks to share the experience gained from these to ensure the discussions on the strategic dimensions of FDA are Organise several FDA-11: informed by practical evidence. Sessions (including sessions/workshops to but not limited to those detailed below) should share lessons learned and FDA AHT and focus on several issues ranging from technical to Q4 2018 outcomes from FDA programmatic lessons learned will be shared and systems and platform considered as input for the definition of technical pilots and Interoperability FDA recommendations. Projects. WGISS-45, FDA workshop, 11/04 SIT-33, 24-25/04 FDA Big Data Workshop, 26/04 Boulder SIT Technical Workshop, 12-13/09 FDA-12: Inventory of Develop an inventory of current product format space data product Q4 2019 WGCV used in CEOS agencies and identify formats used by CEOS recommendations to facilitate interoperability. agencies. Future Data Architectures Objectives/Deliverables: 2018-2020 Projected Objective/Deliverable Background Information Responsible Completion CEOS Entity Date User Metrics
FDA-10: Finalise inventory of Software and Tools available or used at CEOS agencies for EO data exploitation and use focusing on Open Source but remaining as broad and inclusive as possible and implement a mechanism for discovery and access. Q3 2018 Each CEOS agency will continue to develop its data and computational infrastructures consistent with its capacity and user service mandates. CEOS has a role in identifying tools to support complementarity and interoperability across CEOS agencies in support of the FDA strategy objectives. WGISS will finalise the ongoing work of inventorying the software and tools available or used at CEOS agencies for EO data exploitation and use (e.g. EO data visualization, analysis, processing, readers/writers, etc), and implement a mechanism for discovery and access. Focus will be on Open Source but remaining as broad and inclusive as possible. WGISS Data, Processing, and Architecture Interface Standards FDA-11: Organise several sessions/workshops to share lessons learned and outcomes from FDA systems and platform pilots and Interoperability Projects. Q4 2018 Several CEOS agencies have already carried out initial pilot projects and CEOS seeks to share the experience gained from these to ensure the discussions on the strategic dimensions of FDA are informed by practical evidence. Sessions (including but not limited to those detailed below) should focus on several issues ranging from technical to programmatic lessons learned will be shared and considered as input for the definition of technical FDA recommendations. WGISS-45, FDA workshop, 11/04 SIT-33, 24-25/04 FDA Big Data Workshop, 26/04 Boulder SIT Technical Workshop, 12-13/09 FDA AHT and FDA-12: Inventory of space data product formats used by CEOS agencies. Q4 2019 Develop an inventory of current product format used in CEOS agencies and identify recommendations to facilitate interoperability. WGCV Future Data Architectures Objectives/Deliverables: 2018-2020 Objective/Deliverable Projected Completion Date Background Information Responsible CEOS Entity User Metrics
CEOS%20Work%20Plan2018-2020v1.docx